Get the Stockscreener App
102.11
3.31%
-3.2738
Icon Plc stock is traded at $102.11, with a volume of 383.03K.
It is down -3.31% in the last 24 hours and up +27.24% over the past month.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
See More
Previous Close:
$105.38
Open:
$104.35
24h Volume:
383.03K
Relative Volume:
0.22
Market Cap:
$7.78B
Revenue:
$8.10B
Net Income/Loss:
$599.48M
P/E Ratio:
13.80
EPS:
7.3969
Net Cash Flow:
$971.54M
1W Performance:
-7.87%
1M Performance:
+27.24%
6M Performance:
-41.77%
1Y Performance:
-44.44%
1-Day Range:
$101.60
$107.12
1-Week Range:
$101.89
$110.41
52-Week Range:
$66.57
$211.00
Icon Plc Stock (ICLR) Company Profile
Compare ICLR vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
101.89 | 8.05B | 8.10B | 599.48M | 971.54M | 7.3969 |
|
TMO
Thermo Fisher Scientific Inc
|
476.06 | 184.15B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
189.00 | 137.93B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
578.37 | 47.82B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.95 | 32.62B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
288.17 | 29.19B | 3.17B | 642.63M | 516.49M | 10.77 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-23-26 | Upgrade | Jefferies | Hold → Buy |
| Feb-18-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-17-26 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Feb-12-26 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-12-26 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jan-08-26 | Downgrade | Truist | Buy → Hold |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-09-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-03-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Aug-21-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-24-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-29-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-21-25 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Neutral |
| Sep-18-24 | Initiated | Leerink Partners | Outperform |
| Jun-06-24 | Initiated | Goldman | Buy |
| Dec-15-23 | Initiated | Truist | Buy |
| Sep-13-23 | Initiated | TD Cowen | Outperform |
| Jan-17-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-13-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-07-22 | Initiated | UBS | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-21 | Initiated | Citigroup | Neutral |
| Apr-13-21 | Resumed | BofA Securities | Neutral |
| Apr-01-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-08-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-03-21 | Initiated | Barclays | Equal Weight |
| Mar-01-21 | Upgrade | UBS | Neutral → Buy |
| Feb-26-21 | Upgrade | Truist | Hold → Buy |
| Jul-24-20 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-20-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Hold |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Sep-23-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-26-19 | Upgrade | UBS | Sell → Neutral |
| Jan-25-19 | Upgrade | Mizuho | Neutral → Buy |
| Oct-26-18 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-09-18 | Initiated | UBS | Sell |
| Apr-03-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-18 | Reiterated | Mizuho | Neutral |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
| Oct-27-17 | Reiterated | Barclays | Equal Weight |
| Sep-11-17 | Initiated | BofA/Merrill | Buy |
| Jul-31-17 | Upgrade | SunTrust | Hold → Buy |
| Jul-27-17 | Reiterated | Mizuho | Neutral |
| Jun-29-17 | Upgrade | Jefferies | Hold → Buy |
View All
Icon Plc Stock (ICLR) Latest News
Franklin Resources Inc. Purchases 719,301 Shares of Icon Plc $ICLR - MarketBeat
Russell Investments Group Ltd. Buys 68,493 Shares of Icon Plc $ICLR - MarketBeat
Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More - AOL.com
Icon price target lowered to $120 from $200 at Citi - Bitget
Polen Global Growth Strategy Sold ICON plc (ICLR) Due to Short-Term Growth Challenges - Finviz
Icon earnings on deck amid accounting probe uncertainty - Investing.com Australia
Icon earnings on deck amid accounting probe uncertainty By Investing.com - Investing.com Canada
Icon Plc $ICLR Stake Lessened by Neuberger Berman Group LLC - MarketBeat
ICON plc options imply 4.1% move in share price post-earnings - TipRanks
Barclays cuts ICON stock price target on accounting uncertainty By Investing.com - Investing.com UK
Barclays cuts ICON stock price target on accounting uncertainty - Investing.com
Handelsbanken Fonder AB Sells 9,064 Shares of Icon Plc $ICLR - MarketBeat
ICON plc Under Investigation for Possible Securities Fraud - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plcICLR - PR Newswire
Jefferies Upgrades ICON Public Limited Company (ICLR) to Buy from Hold - Finviz
ICLR (NASDAQ: ICLR) files Form 144 for 566 vested restricted shares on 03/03/2026 - Stock Titan
71,675 Shares in Icon Plc $ICLR Purchased by Arvin Capital Management LP - MarketBeat
American Century Companies Inc. Cuts Holdings in Icon Plc $ICLR - MarketBeat
Finemark National Bank & Trust Has $458,000 Stake in Icon Plc $ICLR - MarketBeat
ICLR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Icon Plc (NASDAQ:ICLR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
ICON plcOrdinary Shares (NQ: ICLR - The Chronicle-Journal
ICON Plc (ICLR) Stock Analysis: Unpacking The 37% Upside Potential - DirectorsTalk Interviews
JPMorgan Chase & Co. Decreases Holdings in Icon Plc $ICLR - MarketBeat
ICON plc Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Icon Plc (NASDAQ:ICLR) Short Interest Down 29.2% in February - MarketBeat
Jefferies Bullish on ICON (ICLR) Despite Share Price Decline - Finviz
ICON plc Opens with a 5.16% Gain After Recent Decline of 44.25% - Markets Mojo
Icon plc under the microscope over ‘misstated’ clinical trial revenue - The Times
Keystone Investors PTE Ltd. Takes Position in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Icon (NASDAQ:ICLR) Downgraded by Zacks Research to "Strong Sell" - MarketBeat
Icon Plc $ICLR Shares Sold by Artisan Partners Limited Partnership - MarketBeat
Westfield Capital Management Co. LP Has $69.36 Million Stake in Icon Plc $ICLR - MarketBeat
Ademi LLP Investigates Claims of Securities Fraud against ICON plc - ChartMill
Thornburg Investment Management Inc. Sells 17,435 Shares of Icon Plc $ICLR - MarketBeat
Internship for Life Science Students at ICON Careers | Opportunity for Life Science Students - BioTecNika
ICON’s Accounting Review And Legal Scrutiny Could Be A Game Changer For ICON (ICLR) - Sahm
Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plcICLR - marketscreener.com
Here is Why ICON Public Limited Company (ICLR) Offers an Impressive Upside - Finviz
ICON plc earnings delayed to April as accounting investigation unfolds By Investing.com - Investing.com Canada
Clinical Research Provider Icon Stock Crashes On Accounting Probe - AOL.com
ICON plc (ICLR) Stock Analysis: Exploring the 58% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
ICLR: Jefferies Upgrades Icon with Lowered Price Target | ICLR S - GuruFocus
Aberdeen Group plc Lowers Position in Icon Plc $ICLR - MarketBeat
ICON PLC (ICON) soars 16% as analyst issues 'hold', $93 PT despite accounting concerns - MSN
Jefferies upgrades ICON stock on valuation despite lower target By Investing.com - Investing.com UK
Jefferies upgrades ICON stock on valuation despite lower target - Investing.com
2026-02-22 | ICON plc (ICLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ICLR | Press Release - Stockhouse
Icon Plc Stock (ICLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.51%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):